Skip to main content

Heska Corp

HSKADelisted Jun 13, 2023
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001038133

Heska Corp was delisted on Jun 13, 2023; its insiders filed their last Form 4 on Jun 14, 2023; 152 institutions reported holding it in 13F filings for Q1 2023, worth $1.01B in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Heska Corp changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of HSKA: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders185170−15
Shares10.4M10.4M+83.5K (+0.8%)
Value$1.89B$1.44B−$445.4M (−23.6%)

New holders (15)

Institutions that held Heska Corp at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to HSKA in Q1 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC54,108$7.48M0.01%
Alberta Investment Management Corp13,337$1.84M0.01%
Monarch Partners Asset Management LLC11,205$1.55M0.35%
Squarepoint Ops LLC6,751$934.0K0.01%
Trexquant Investment LP5,459$755.0K0.04%
Amalgamated Financial Corp.5,116$707.0K0.01%
Algert Global LLC3,239$448.0K0.03%
Simplex Trading, LLC1,773$245.0K0.01%
Point72 Hong Kong Ltd415$57.0K0.01%
Global Retirement Partners, LLC182$17.0K0.00%
GHP Investment Advisors, Inc.61$8.00K0.00%
Allworth Financial LP40$6.00K0.00%
Signaturefd, LLC11$2.00K0.00%
CWM, LLC5$1.00K0.00%
Quadrant Capital Group LLC4$1.00K0.00%

Sold out (30)

Institutions that held Heska Corp at the end of Q4 2021 and filed for Q1 2022 without it.